| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
and IL-4 in Controlling Respiratory Mycoplasma Infection and Disease1
* Department of Molecular Biology and Immunology, University of North Texas Health Science Center, Fort Worth, TX 76107;
Department of Psychiatry andBehavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322; and
Department of Genetics, Division of Genomics, University of Alabama, Birmingham, AL 35294
The purpose of this study is to evaluate the significance of IFN-
and IL-4 production in controlling mycoplasma infection and the pathogenesis of disease in the upper and lower respiratory tract. By using IFN- knockout and IL-4 knockout BALB/c mice, we were able to study the contribution of these cytokines in the development of pathogenesis and/or protection in response to mycoplasma respiratory infection, in both the upper and lower respiratory tracts. The loss of either IFN- or IL-4 does not affect disease pathogenesis or mycoplasma organism numbers in the upper respiratory tract. However, in the absence of IL-4, the nasal passages developed a compensatory immune response, characterized by higher numbers of macrophages and CD8+ T cells, which may be masking detrimental effects due to IL-4 deficiency. This is in contrast to the lower respiratory tract, where the loss of IFN-, but not IL-4, leads to higher mycoplasma numbers and increased disease severity. The loss of IFN- impacted the innate immune system’s ability to effectively clear mycoplasma, as the number of organisms was higher by day 3 postinfection. This higher organism burden most likely impacted disease pathogenesis; however, the development of Th2 cell-mediated adaptive immune response most likely contributed to lesion severity at later time points during infection. Our studies demonstrate that the upper and lower respiratory tracts are separate and distinct in their cytokine requirements for generating immunity against mycoplasma infection.
This article has been cited by other articles:
|
|
 |
|
  M. D. Woolard, L. L. Hensley, T. H. Kawula, and J. A. Frelinger Respiratory Francisella tularensis Live Vaccine Strain Infection Induces Th17 Cells and Prostaglandin E2, Which Inhibits Generation of Gamma Interferon-Positive T Cells Infect. Immun., June 1, 2008; 76(6): 2651 - 2659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Wu, R. J. Martin, S. LaFasto, B. J. Efaw, J. G. Rino, R. J. Harbeck, and H. W. Chu Toll-like Receptor 2 Down-regulation in Established Mouse Allergic Lungs Contributes to Decreased Mycoplasma Clearance Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 720 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Salvatore, M. Fonseca-Aten, K. Katz-Gaynor, A. M. Gomez, A. Mejias, C. Somers, S. Chavez-Bueno, G. H. McCracken, and R. D. Hardy Respiratory Tract Infection with Mycoplasma pneumoniae in Interleukin-12 Knockout Mice Results in Improved Bacterial Clearance and Reduced Pulmonary Inflammation Infect. Immun., January 1, 2007; 75(1): 236 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Sun, H. P. Jones, L. M. Hodge, and J. W. Simecka Cytokine and Chemokine Transcription Profile during Mycoplasma pulmonis Infection in Susceptible and Resistant Strains of Mice: Macrophage Inflammatory Protein 1{beta} (CCL4) and Monocyte Chemoattractant Protein 2 (CCL8) and Accumulation of CCR5+ Th Cells. Infect. Immun., October 1, 2006; 74(10): 5943 - 5954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Bakshi, M. Malik, P. M. Carrico, and T. J. Sellati T-bet Deficiency Facilitates Airway Colonization by Mycoplasma pulmonis in a Murine Model of Asthma J. Immunol., August 1, 2006; 177(3): 1786 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Kirimanjeswara, P. B. Mann, M. Pilione, M. J. Kennett, and E. T. Harvill The Complex Mechanism of Antibody-Mediated Clearance of Bordetella from the Lungs Requires TLR4 J. Immunol., December 1, 2005; 175(11): 7504 - 7511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Fehri, P. Sirand-Pugnet, G. Gourgues, G. Jan, H. Wroblewski, and A. Blanchard Resistance to Antimicrobial Peptides and Stress Response in Mycoplasma pulmonis Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4154 - 4165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Woolard, D. Hudig, L. Tabor, J. A. Ivey, and J. W. Simecka NK Cells in Gamma-Interferon-Deficient Mice Suppress Lung Innate Immunity against Mycoplasma spp. Infect. Immun., October 1, 2005; 73(10): 6742 - 6751. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
